[ESPR] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[ESPR] Esperion Therapeutics, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -26.11%
YoY- -37.00%
Quarter Report
ESPR's Result
ESPR's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 212,236 1,840 982 981 982 145,419 184,474 9.80%
PBT 124,611 -78,249 -61,946 -68,377 -54,221 87,379 -60,039 -
Tax 4,721 4,539 5,165 5,383 0 0 -74 -
NP 124,611 -78,249 -61,946 -68,377 -54,221 87,379 -60,039 -
Tax Rate -3.79% - - - - 0.00% - -
Total Cost 87,625 80,089 62,928 69,358 55,203 58,040 244,513 -49.57%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 58.71 -4,252.66 -6,308.15 -6,970.13 -5,521.49 60.09 -32.55 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS 4.50 -2.84 -2.26 -2.52 -2.01 3.26 -2.24 -
EPS Diluted 4.32 -2.84 -2.26 -2.52 -2.01 3.07 -2.24 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.